Investing.com - Smith & Wesson (NASDAQ: SWBI) reported second quarter EPS of $0.11, $0.06 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $129.7M versus the consensus estimate of $132.42M.
Smith & Wesson's stock price closed at $13.63. It is up 6.07% in the last 3 months and down -4.15% in the last 12 months.
Smith & Wesson saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Smith & Wesson's stock price’s past reactions to earnings here.
According to InvestingPro, Smith & Wesson's Financial Health score is "fair performance".
Check out Smith & Wesson's recent earnings performance, and Smith & Wesson's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar